linkedin post 2016-02-07 06:02:31
SYROS PHARMACEUTICALS: "blocking of a few master genetic switches associated with “super enhancers” might be a simple cure for cancer, says Dr. Richard Young, of Whitehead research institute" and founder of Syros. They raised $83.1 M in two rounds, https://lnkd.in/eSdUNqN View in LinkedIn